FDA, HIV Treatment and Prevention Agents and Pharmaceutical Companies

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

FDA

HIV Treatment and Prevention Agents

Pharmaceutical Companies

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. The initial pandemic lockdowns prevented many patients from seeing doctors face-to-face. The scope of the problem.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Vaccines Pharmaceutical Companies Pharmaceutical Companies

Agile, Data-Driven Life Cycle Management for Continuous Manufacturing

ISPE

JULY 6, 2023

1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. Table 1: List of FDA-approved commercial products using CM elements. Table 1: List of FDA-approved commercial products using CM elements. This is demonstrated by the rise from $1.05

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Dosage Pharmaceutical Companies Pharmaceutical Companies

Webinars

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

MORE WEBINARS

Pharmacy Technician Pulse

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

Agile, Data-Driven Life Cycle Management for Continuous Manufacturing

Webinars

Stay Connected